Despite the near-universal loss of ATRX in ALT cancers, and capacity to suppress the ALT pathway upon re-expression in established ALT cell lines, isolated loss of the gene is insufficient to induce the ALT phenotype in most cellular systems [15]. The gene discussed is GPT; the disease is cancer.